APC and Smad7 link TGFβ type I receptors to the microtubule system to promote cell migration

Molecular Biology of the Cell

Volumn 23, Issue 11, 2012, Pages 2109-2121

  Ekman, Maria ^a   Mu, Yabing ^a,b,c   Lee, So Young ^a   Edlund, Sofia ^a   Kozakai, Takaharu ^a   Thakur, Noopur ^a   Tran, Hoanh ^d   Qian, Jiang ^e   Groeden, Joanna ^e   Heldin, Carl Henrik ^a   Landström, Maréne ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b JILIN UNIVERSITY   (China)

^c UMEÅ UNIVERSITY   (Sweden)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; APC PROTEIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ARTICLE; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; ENZYME INACTIVATION; GENE FUNCTION; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ACTIN CYTOSKELETON; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MICE; MICROTUBULES; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PSEUDOPODIA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84861672509     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-12-1000     Document Type: Article

References (57)

1. Barth AI, Caro-Gonzalez HY, Nelson WJ (2008). Role of adenomatous polyposis coli (APC) and microtubules in directional cell migration and neuronal polarization. Semin Cell Dev Biol 19, 245-251.
2. Bienz M (2002). The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 5, 328-338.
3. Bikkavilli RK, Feigin ME, Malbon CC (2008). p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. J Cell Sci 121, 3598-3607.
4. Brodin G, ten Dijke P, Funa K, Heldin CH, Landström M (1999). Increased Smad expression and activation is associated with apoptosis in normal and malignant prostate after castration. Cancer Res 59, 2731-2738. (Pubitemid 29269123)
5. Castañares C, Redondo-Horcajo M, Magán-Marchal N, ten Dijke P, Lamas S, Rodríguez-Pascual F (2007). Signaling by ALK5 mediates TGF-β-induced ET-1 expression in endothelial cells: a role for migration and proliferation. J Cell Sci 120, 1256-1266.
6. Cheon SS, Nadesan P, Poon R, Alman BA (2004). Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res 293, 267-274. (Pubitemid 38083216)
7. Derynck R, Zhang YE (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584. (Pubitemid 37280136)
8. Dikovskaya D, Zumbrunn J, Penman GA, Nathke IS (2001). The adenomatous polyposis coli protein: in the limelight out at the edge. Trends Cell Biol 11, 378-384. (Pubitemid 32900530)
9. Disanza A, Steffen A, Hertzog M, Frittoli E, Rottner K, Scita G (2005). Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement. Cell Mol Life Sci 62, 955-970. (Pubitemid 40655613)
10. Dobashi Y, Bhattacharjee RN, Toyoshima K, Akiyama T (1996). Upregulation of the APC gene product during neuronal differentiation of rat pheochromocytoma PC12 cells. Biochem Biophys Res Commun 224, 479-483. (Pubitemid 26268212)
11. Doble BW, Woodgett JR (2003). GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116, 1175-1186. (Pubitemid 36410657)
12. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landström M (2003). Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 2, 529-544. (Pubitemid 36237014)
13. Edlund S, Landstrom M, Heldin CH, Aspenstrom P (2004). Smad7 is required for TGF-β-induced activation of the small GTPase Cdc42. J Cell Sci 117, 1835-1847.
14. Edlund S, Lee SY, Grimsby S, Zhang S, Aspenström P, Heldin CH, Landström M (2005). Interaction between Smad7 and β-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol 4, 1475-1488. (Pubitemid 40204923)
15. Etienne-Manneville S (2004). Actin and microtubules in cell motility: which one is in control? Traffic 7, 470-477.
16. Etienne-Manneville S (2008). Polarity proteins in migration and invasion. Oncogene 27, 6970-6980.
17. Etienne-Manneville S, Hall A (2003). Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity. Nature 421, 753-756. (Pubitemid 36227627)
18. Franzen P, Ichijo H, Miyazono K (1993). Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp Cell Res 207, 1-7. (Pubitemid 23192157)
19. Han G et al. (2006). Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev Cell 3, 301-312. (Pubitemid 44283940)
20. Hayashi H et al. (1997). The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165-1173. (Pubitemid 127678749)
21. Heldin CH, Landström M, Moustakas A (2009). Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2, 166-176.
22. Huttenlocher A (2005). Cell polarization mechanisms during directed cell migration. Nat Cell Biol 7, 336-337.
23. Jope RS, Johnson GV (2004). The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2, 95-102. (Pubitemid 38186580)
24. Javelaud D, Delmas V, Möller M, Sextius P, André J, Menashi S, Larue Mauviel A (2005). Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene 24, 7624-7629. (Pubitemid 41638037)
25. Johnson SA, Hunter T (2005). Kinomics: methods for deciphering the kinome. Nat Methods 1, 17-25. (Pubitemid 41131053)
26. Kroboth K, Newton IP, Kita K, Dikovskaya D, Zumbrunn J, Waterman-Storer CM, Näthke IS (2007). Lack of adenomatous polyposis coli protein correlates with a decrease in cell migration and overall changes in microtubule stability. Mol Biol Cell 18, 910-918. (Pubitemid 46399496)
27. Landström M, Heldin NE, Bu S, Hermansson A, Itoh S, ten Dijke P, Heldin CH (2000). Smad7 mediates TGF-β1 induced apoptosis in prostatic carcinoma cells. Curr Biol 10, 535-538. (Pubitemid 30308312)
28. Massagué J (2000). How cells read TGF-β signals. Nat Rev 1, 169-178.
29. Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G, Atfi A (2001). Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem 276, 36797-36803.
30. McCartney BM, Näthke IS (2008). Cell regulation by the APC protein: APC as master regulator of epithelia. Curr Opin Cell Biol 20, 186-193.
31. Moustakas A, Heldin CH (2008). Dynamic control of TGF-beta signaling and its links to the cytoskeleton. FEBS Lett 582, 2051-2065.
32. Mu Y, Gudey SK, Landström M (2012). Non-Smad signaling pathways. Cell Tissue Res 347, 11-20.
33. Mu Y et al. (2011). TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer. Nature Commun 2, 330.
34. Nakao A et al. (1997). Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 631-635. (Pubitemid 27446184)
35. Nelson WJ, Nusse R (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303, 1483-1487.
36. Näthke I (2006). Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC. Nat Rev Cancer 6, 967-974.
37. Näthke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ (1996). The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 134, 165-179.
38. Pollard TD, Borisy GG (2003). Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453-465.
39. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, Ambrosino C, Benito M, Nebreda AR (2004). P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 2, 922-933.
40. Raftopoulou M, Hall A (2004). Cell migration: Rho GTPases lead the way. Dev Biol 265, 23-32.
41. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003). Cell migration: integrating signals from front to back. Science 302, 1704-1709. (Pubitemid 37505725)
42. Satterwhite DJ, Neufeld KL (2004). TGF-β targets the Wnt pathway components, APC and β-catenin, as Mv1Lu cells undergo cell cycle arrest. Cell Cycle 3:8, 1069-1073. (Pubitemid 40268667)
43. Sharma M, Leung L, Brocardo M, Henderson J, Flegg C, Henderson BR (2006). Membrane localization of adenomatous polyposis coli protein at cellular protrusions: targeting sequences and regulation by beta-catenin. J Biol Chem 281, 17140-17149.
44. Shi Y, Massagué J (2003). Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700. (Pubitemid 36724933)
45. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landström M (2008). The type I TGF-β receptor engages TRAF6 to distinguish activation of TAK1 from the canonical Smad-pathway. Nat Cell Biol 10, 1199-207.
46. Souchelnytskyi S, Nakayama T, Nakao A, Morén A, Heldin CH, Christian JL, ten Dijke P (1998). Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. J Biol Chem 273, 25364-25370.
47. Tang Y, Liu Z, Zhao L, Clemens TL, Cao X (2008). Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J Biol Chem 283, 23956-23963.
48. Thiery JP, Acloque H, Huang RY, Nieto MA (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
49. Thornton TM et al. (2008). Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320, 667-670. (Pubitemid 351928349)
50. Valle L et al. (2008). Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 321, 1361-1365.
51. Votin V, Nelson WJ, Barth AI (2005). Neurite outgrowth involves adenomatous polyposis coli protein and beta-catenin. J Cell Sci 118, 5699-5708. (Pubitemid 43079264)
52. Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJ, Chen M, Gomes ER (2004). EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol 6, 820-830. (Pubitemid 39207247)
53. Woodgett JR (2005). Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 2, 150-157.
54. Xu J, Lamouille S, Derynck R (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2, 156-172.
55. Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG (2004). Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64, 1975-1986. (Pubitemid 38339443)
56. Zhou FQ, Zhou J, Dedhar S, Wu YH, Snider WD (2004). NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42, 897-912.
57. Zohn IE, Li Y, Skolnik EY, Anderson KV, Han J, Niswander L (2006). p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 125, 957-969.